David A. Weber
34Patents
11h-index
27Co-inventors
71Inventor score
Filing activity: Sep 18, 2002 → May 14, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7090681B2 | Methods and apparatus for delivery of ocular implants | Human Necessities | 191 | Expired |
| US6899717B2 | Methods and apparatus for delivery of ocular implants | Human Necessities | 132 | Expired |
| US7468065B2 | Apparatus for delivery of ocular implants | Human Necessities | 106 | Active |
| US8911768B2 | Methods for treating retinopathy with extended therapeutic effect | Chemistry; Metallurgy | 62 | Active |
| US7753916B2 | Methods and apparatus for delivery of ocular implants | Human Necessities | 40 | Active |
| US8318070B2 | Ocular implant made by a double extrusion process | Human Necessities | 36 | Active |
| US7147644B2 | Apparatus for delivery of ocular implants | Human Necessities | 27 | Expired |
| US8034370B2 | Ocular implant made by a double extrusion process | Human Necessities | 19 | Active |
| US8663639B2 | Formulations for treating ocular diseases and conditions | Human Necessities | 18 | Active |
| US8034366B2 | Ocular implant made by a double extrusion process | Human Necessities | 17 | Active |
| US8048445B2 | Ocular implant made by a double extrusion process | Human Necessities | 13 | Active |
| US8124736B2 | Alpha-1-antitrypsin compositions | Physics | 8 | Active |
| US8367097B2 | Liquid formulations for treatment of diseases or conditions | Human Necessities | 8 | Active |
| US8802129B2 | Methods for treating retinopathy with extended therapeutic effect | Chemistry; Metallurgy | 6 | Active |
| US8506987B2 | Ocular implant made by a double extrusion process | Human Necessities | 5 | Active |
| US9192511B2 | Ocular implant made by a double extrusion process | Human Necessities | 5 | Active |
| US7777006B2 | Method for purification of alpha-1-antitrypsin | Physics | 5 | Expired |
| US8722624B2 | Alpha-1-antitrypsin compositions and methods of use | Physics | 4 | Active |
| US8637070B2 | Rapamycin formulations and methods of their use | Human Necessities | 3 | Active |
| US10076526B2 | Ocular implant made by a double extrusion process | Human Necessities | 3 | Active |
| US8222271B2 | Formulations and methods for vascular permeability-related diseases or conditions | Human Necessities | 3 | Active |
| US8927005B2 | Liquid formulations for treatment of diseases or conditions | Human Necessities | 2 | Active |
| US9320783B2 | Methods of treatment using alpha-1-antitrypsin compositions | Physics | 2 | Active |
| US9387165B2 | Rapamycin formulations and methods of their use | Human Necessities | 2 | Active |
| US10335467B2 | Methods of treatment using alpha-1-antitrypsin compositions | Physics | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.